2.4 Exposure definition The primary exposure was GLP-1 RA use, defined as any documented prescription fill for a GLP-1 RA (liraglutide, semaglutide, exenatide, and dulaglutide) at least 90 days prior to the index date, based on prescription records in the electronic health record
Sermorelin may fit men with slower recovery, lower energy, or age-related changes in body composition, while BPC-157, TB-500, and collagen peptides may be more relevant when joint, tendon, or soft tissue issues limit training
The savviest GLP-1 users approach supplementation as a personalized protocol rather than a branded system purchase
The Protein-Muscle Problem Research shows that up to 20 to 25 percent of weight lost on GLP-1 medications can come from muscle rather than fat